GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AR, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, GRIK5, GRM5, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1, TYR |
12.5537 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, ESR1, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MET, MIF, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS1, PTGS2, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SRC, TNKS, TNKS2, TRPV1, XDH |
12.5537 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, NR3C1, PIK3CA, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, RORC, SRC, TRPV1, TYR |
11.3241 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APEX1, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, RORC, SRC, TRPV1, TYR |
9.35438 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GRIK5, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TOP2A, TRPV1, XDH |
9.35438 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GRIK5, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TOP2A, TRPV1, XDH |
9.32668 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, NR3C1, PRKCE, PTGS2, RORC, SRC, TYR |
8.98526 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, HSD11B2, NR3C1, PRKCE, PRKCG, PTGS2, RORC, SRC, TRPV1, TYR |
8.95553 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, NR3C1, PPARA, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
8.87528 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GRIK5, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TOP2A, TRPV1, XDH |
8.87528 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH |
8.87528 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TRPV1 |
8.79126 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, NR3C1, PPARA, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
8.23644 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, AR, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, NR3C1, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 |
7.93454 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC1A1, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH |
7.92392 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AR, AXL, CDK6, CYP1B1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, NR3C1, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 |
7.92392 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
7.89623 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, AR, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, NR3C1, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 |
7.62145 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GRM1, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
7.36082 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GRM1, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
7.3304 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SRC, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
7.17208 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, ALOX12, AR, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC |
7.01089 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, ALOX12, AR, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC |
6.92058 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
6.85655 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PGR, PIM1, PPARA, RORC, SRC |
6.6507 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, AR, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MIF, MMP2, MMP9, NR3C1, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1 |
6.37687 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH |
6.34764 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.30645 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.30645 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, ALOX12, AR, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MIF, MMP9, PIK3CA, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC |
6.30645 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.26922 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, AR, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, GRM1, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
6.16923 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, ALOX12, AR, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PGR, PIM1, PRKCA, PTGS1, PTGS2, SRC, XDH |
6.16923 |
[BP] GO:0030168 |
platelet activation
|
AXL, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
6.14564 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA3, AXL, BCL2, CA1, CSNK2A1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC, TNKS, TNKS2, TRPV1 |
6.09761 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
AR, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH |
5.99124 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
5.95442 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
5.92394 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, FABP3, HSD11B2, KDR, NR3C1, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TRPV1 |
5.81164 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GBA2, GLO1, MIF, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
5.78909 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, KDR, NR3C1, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
5.7331 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
5.73143 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GRM3, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH |
5.72232 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH |
5.71785 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, AKR1B1, AR, AXL, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1 |
5.63417 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
5.63417 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA3, AKR1B1, ALPL, APEX1, AR, AURKB, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD11B2, HSD17B2, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, TYR |
5.56064 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, AR, AXL, BCL2, CSNK2A1, CYP1B1, ESRRA, F3, FABP4, FLT3, GRM1, KDR, MET, MIF, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
5.53217 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, AR, AXL, BCL2, CYP1B1, F3, FLT3, GRM1, KDR, MET, MIF, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCE, PTGS2, PTPN1, SRC, XDH |
5.52201 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.48155 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
5.48129 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, AR, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F3, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PRKCA, PTGS2 |
5.46991 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
5.46981 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.45478 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF, PTGS1, PTGS2 |
5.44396 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA3, ALOX12, APEX1, AR, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, F3, GRIK5, GRM5, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TRPV1 |
5.42746 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX12, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
5.41806 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
5.35639 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PRKCD, PTGS2, SRC |
5.31252 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF, PTGS1, PTGS2 |
5.24185 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MIF, PIK3CA, PIK3CB, PTGS1, PTGS2 |
5.22592 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CDK6, KDR, MIF, PIK3CB, PRKCE, PTGS2, SRC, TNKS, TNKS2, TRPV1 |
5.18767 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS |
5.14994 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
5.14994 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX12, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, MET, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
4.96206 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GRM3, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH |
4.95125 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.94875 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, AR, CYP1A1, CYP1B1, ESR1, FLT3, NR3C1, PTGS2, RORC, SRC, TRPV1 |
4.88359 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS |
4.88359 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
4.8763 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRM1, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.8419 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, APEX1, AR, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD17B2, KDR, MET, MIF, MMP2, MMP9, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCD, PTGS2, RORC, SRC, TNKS2, TOP2A, TYR |
4.8287 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
AR, BCL2, CDC25B, ESRRB, FLT3, GRM1, GRM5, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.8287 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, GRM1, GRM5, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.80893 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, GRM1, GRM5, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.80893 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, ALOX12, APEX1, AXL, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, PIK3CA, PIK3CB, PRKCB, PRKCE, SRC, TRPV1 |
4.64376 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
AR, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.6351 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, AR, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F3, FABP4, GRM1, GRM5, GRM8, HSD11B2, HSD17B2, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PRKCD, PRKCG, PTGS2, RORC, SRC, TNKS2, TRPV1, TYR |
4.63051 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
AR, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.58036 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, ALOX12, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, PRKCA, PRKCE, PTGS2, SRC |
4.56952 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
4.54903 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS |
4.54584 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS |
4.53147 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
4.52877 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
APEX1, AR, AURKB, BCL2, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PIK3CA, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
4.47144 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, ALOX12, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, MET, PIK3CA, PIK3CB, PRKCB, PRKCE, TRPV1 |
4.46814 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
AR, BCL2, CDC25B, FLT3, GRM1, GRM5, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.4621 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APEX1, AR, AURKB, BCL2, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, IGF1R, MET, MIF, MMP12, MMP9, NR3C1, PIK3CA, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
4.37029 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PIK3CA, PPARA, SRC, TYR |
4.35912 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TRPV1, TYR |
4.33602 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, XDH |
4.29436 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, ALOX12, APEX1, BCL2, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, PRKCA, PRKCE, PTGS2, SRC |
4.25211 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.24798 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.21256 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.19275 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, ALOX12, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, PRKCA, PRKCE, PTGS2, SRC |
4.15818 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA3, ALOX12, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MIF, MMP9, PRKCA, PRKCE, PTGS2, SRC |
4.14293 |
[BP] GO:0006855 |
None
|
SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 |
4.14293 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PRKCA, PRKCE, SLC22A1 |
4.13455 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
4.12569 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, GRM5, HSD11B2, IGF1R, PPARA, PRKCD, PTGS2, SRC, TRPV1 |
4.10984 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF, PTGS1, PTGS2 |
4.09563 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, PRKCD, SRC |
4.04129 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.04129 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, PRKCD, SRC |
4.04129 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, ESR1, PGR, PPARA, PRKCG, RORC, SRC, TOP2A |
4.02434 |
[BP] GO:0042325 |
regulation of phosphorylation
|
AR, BCL2, CDC25B, ESRRB, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.02351 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, HSD11B2, NR3C1, PTGS2, SRC |
4.01141 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX12, ALOX5, MIF, PTGS1, PTGS2 |
4.00366 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, XDH |
3.97723 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TRPV1, TYR |
3.96633 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS |
3.88846 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PPARA, PTGS1, PTGS2 |
3.88541 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, CA2, CA7, GRIK5, GRM1, GRM3, GRM5, GRM8, PRKCE, PTGS2 |
3.82541 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, CA2, CA7, GRIK5, GRM1, GRM3, GRM5, GRM8, PRKCE, PTGS2 |
3.82541 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, GRIA2, GRIA4, GRIK5, PPARA, PRKCB, PRKCE, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, TRPV1 |
3.81512 |
[BP] GO:0001775 |
cell activation
|
ALOX5, AXL, BCL2, FLT3, FUT7, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TRPV1 |
3.77957 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, PRKCD, PRKCE |
3.77583 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA3, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH |
3.77583 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, PRKCD, SRC |
3.77311 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA3, APEX1, AR, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH |
3.75514 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, ESR1, FLT3, MET, MIF, PIK3CB, PIM1, PRKCD, SRC, TYR |
3.7449 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA3, APEX1, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH |
3.72155 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PRKCD, PRKCE, PTGS2, SRC |
3.71843 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, PRKCA, PRKCB, PRKCD, TNKS |
3.71808 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, NR3C1, PGR, SRC |
3.71808 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
3.68231 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, GLO1, MIF, PPARA, PTGS1, PTGS2 |
3.67871 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, FLT3, IGF1R, KDR, MET, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS, TOP2A |
3.64208 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, KDR, PRKCD, PRKCE, SRC |
3.60858 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, ALOX12, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GRM1, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
3.57944 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA3, APEX1, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH |
3.57862 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, AR, ESR1, FLT3, GRM5, IGF1R, MMP2, NR3C1, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
3.56469 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, CSNK2A1, PRKCA, PRKCB, PRKCD, TNKS |
3.53219 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC |
3.52587 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SRC |
3.50613 |
[BP] GO:0051172 |
None
|
APEX1, AR, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, IGF1R, MIF, MMP12, MMP9, NR3C1, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
3.50613 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
AR, BCL2, CDC25B, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.50613 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA3, APEX1, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH |
3.48915 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, PRKCG, SRC |
3.45476 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SRC |
3.41127 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, PRKCD, PTGS1, PTGS2, SRC |
3.40932 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ALOX12, AR, AXL, BCL2, CA2, CYP1B1, ESRRB, F3, KDR, MET, MIF, MMP12, MMP9, PIM1, PRKCA, PRKCB, PRKCE, PTGS2, SLC1A1, SRC, TRPV1 |
3.40297 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.34619 |
[BP] GO:0032845 |
None
|
BCL2, MIF, PRKCE, SRC, TNKS, TNKS2, TRPV1 |
3.33516 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTGS2, PTPN1, SRC |
3.2884 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, BCL2, F3, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
3.26797 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA3, APEX1, AR, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, GRM1, GRM5, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1, XDH |
3.26797 |
[BP] GO:0015893 |
None
|
CA2, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 |
3.26797 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA3, ALOX12, AR, AXL, BCL2, CA2, CDK6, CYP1B1, ESR1, ESRRA, ESRRB, F3, GRM1, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, SLC1A1, SRC, TNKS2, TRPV1, XDH |
3.26507 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA3, AR, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, TRPV1, XDH |
3.22136 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA3, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, XDH |
3.19128 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
3.1816 |
[BP] GO:0080134 |
regulation of response to stress
|
ALOX12, CDK6, CYP19A1, ESR1, F3, FABP4, IGF1R, MET, MIF, MMP12, MMP2, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
3.17459 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
ALOX12, CYP1B1, F3, KDR, PRKCA, PRKCB, PTGS2 |
3.17459 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
AR, BCL2, CDC25B, FLT3, GRM1, GRM5, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.17459 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, HSD11B2, NR3C1, PTGS2, SRC |
3.16438 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SRC |
3.15989 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, BCL2, F3, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
3.15843 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
GRM1, GRM3, GRM5, GRM8, PTGS2 |
3.14196 |
[BP] GO:0044093 |
positive regulation of molecular function
|
AR, AURKB, BCL2, CDC25B, ESR1, ESR2, F3, FLT3, GRM1, GRM5, MET, MIF, MMP9, PIK3CA, PIK3CB, PRKCB, PRKCD, PRKCE, PTPN1, SRC, TNKS, XDH |
3.13963 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, PRKCA, PRKCB, PRKCD |
3.12274 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
AR, BCL2, CDC25B, CSNK2A1, ESR1, F3, FLT3, GRM1, GRM5, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.10193 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, PRKCD |
3.08461 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX12, MIF, PTGS1, PTGS2 |
3.07398 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, BCL2, F3, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
3.06855 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.02326 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ALOX12, CYP19A1, ESR1, F3, FABP4, KDR, MET, MIF, MMP12, PPARA, PRKCA, PRKCD, PRKCG, PTGS2 |
2.99728 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
2.99728 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.99728 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, BCL2, F3, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.94002 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
AR, BCL2, CDC25B, ESR1, F3, FLT3, GRM1, GRM5, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.93479 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, NR3C1, PGR, PPARA, PRKCD, PTGS2, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1 |
2.93075 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, NQO2, PTGS1, RORC |
2.92097 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, PRKCB, PRKCD, PTPN1, SRC |
2.91863 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
ALOX12, CYP1B1, F3, KDR, PRKCA, PRKCB, PTGS2 |
2.87937 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
2.87937 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, PGR, PTGS2, SRC |
2.84804 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, NR3C1, PRKCE, SRC |
2.83756 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, F3, GRIK5, MMP9, PIK3CB, PRKCD, PTGS2, SRC, TOP2A, TRPV1, XDH |
2.79654 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
AR, FLT3, GRM1, KDR, MIF, PIK3CB, PRKCA, PRKCE, PTPN1, SRC, XDH |
2.78371 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
2.78371 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, AXL, BCL2, CA2, CA7, CYP19A1, GRIK5, GRM5, MIF, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TRPV1 |
2.77632 |
[BP] GO:0015872 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.77579 |
[BP] GO:0015697 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.77579 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
AR, FLT3, GRM1, IGF1R, KDR, MIF, PIK3CB, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
2.77221 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, F3, GRIK5, MMP9, PIK3CB, PRKCD, PTGS2, SRC, TOP2A, TRPV1, XDH |
2.77051 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, GRIK5, PTGS2, SLC1A1, SLC22A2, SLC22A3, TRPV1 |
2.76467 |
[BP] GO:0035408 |
None
|
PRKCA, PRKCB |
2.76467 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.76467 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, ESR1, IGF1R, MET, MIF, MMP9, PRKCD, PTGS2, PTPN1, SRC, XDH |
2.76176 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
2.74956 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.72315 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FLT3, GRM1, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
2.72201 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
2.71157 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.69571 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
CA2, CA7, PRKCE |
2.69571 |
[BP] GO:0001516 |
None
|
MIF, PTGS1, PTGS2 |
2.69571 |
[BP] GO:0046457 |
None
|
MIF, PTGS1, PTGS2 |
2.69571 |
[BP] GO:0015695 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC47A1 |
2.68599 |
[BP] GO:0060078 |
None
|
GRIA2, GRIA4, GRIK5, GRM5, TRPV1 |
2.68599 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, PRKCD, SRC |
2.65194 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX12, AR, BCL2, CDK6, CYP19A1, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PRKCB, PRKCD, PTGS2, PTPN1, SRC, XDH |
2.64163 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, GLO1, MIF, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.63646 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, F3, FLT3, FUT7, GBA2, GLO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.6327 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, MMP2, MMP9, PGR, PTGS2, SRC, TOP2A |
2.63176 |
[BP] GO:0031399 |
regulation of protein modification process
|
AR, BCL2, CDC25B, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, XDH |
2.62709 |
[BP] GO:1901570 |
None
|
ALOX12, ALOX5, MIF, PTGS1, PTGS2 |
2.61822 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.61169 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MET, MMP12, NR3C1, PGR, PPARA, PRKCD, PTGS2, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1 |
2.59932 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, CDK6, ESR1, FLT3, NR3C1, PRKCE, RORC, SRC |
2.59932 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, NR3C1, PRKCE, SRC |
2.59835 |
[BP] GO:0007154 |
None
|
AR, AXL, BCL2, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, PGR, PRKCG, PTGS2, SLC1A1, TRPV1 |
2.59565 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, AR, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, IGF1R, KDR, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
2.58832 |
[BP] GO:0044070 |
regulation of anion transport
|
CA2, CA7, GRM5, MIF, PRKCD |
2.57874 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA2, CA7, ESR1, GRIK5, GRM1, GRM5, PIK3CA, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.56414 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, HSD11B2, PPARA, PRKCD, PTGS2, SRC, TRPV1 |
2.55887 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, FABP3, FLT3, PPARA, PRKCD, PRKCE, PTGS2, RORC, SRC |
2.54879 |
[BP] GO:0051937 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.53769 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, FLT3, HSD11B2, NR3C1, PTGS2 |
2.53624 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, PRKCD, SRC |
2.53624 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, BCL2, CA2, CYP1A1, GRM1, HSD11B2, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SRC, TRPV1, TYR |
2.53413 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CYP1B1, F3, GRIK5, MMP9, PIK3CB, PRKCD, PTGS2, SRC, TOP2A, TRPV1, XDH |
2.52641 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, PRKCD, SRC |
2.51455 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, KDR, PRKCE, SRC, TRPV1 |
2.50205 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, ESR1, FABP3, GRM1, GRM5, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.48182 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX12, BCL2, CDK6, CYP1B1, KDR, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, SRC |
2.48182 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, F3, MET, PIK3CA, PIK3CB, SRC, XDH |
2.46987 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, MIF, MMP9, PTGS2, PTPN1, SRC |
2.46987 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.4694 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.4694 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX5, PTGS2 |
2.4694 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC |
2.46075 |
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, BCL2, CA2, CA7, ESR1, GRIK5, GRM1, GRM5, PIK3CA, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.4544 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, IGF1R, PRKCD, PRKCG, SRC, TNKS, TNKS2 |
2.4539 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
2.42963 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
AURKB, CDC25B, FLT3, GRM1, GRM5, MIF, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC, TNKS |
2.40193 |
[BP] GO:0009894 |
regulation of catabolic process
|
APEX1, BCL2, CSNK2A1, ESRRB, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1 |
2.40193 |
[BP] GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress
|
BCL2, CYP1B1, PRKCD |
2.40193 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.40193 |
[BP] GO:0045934 |
None
|
APEX1, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, MMP12, NR3C1, PPARA, PRKCA, RORC, SRC, TNKS, TNKS2, TRPV1 |
2.39854 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.39854 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.39854 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.39854 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.39854 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, AR, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KDR, MMP9, PGR, PIK3CA, PIM1, PPARA, PTGS2, RORC, SRC, TYR |
2.38727 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F3, MET, PIK3CA, PIK3CB, SRC |
2.37392 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, MET, MMP12, NR3C1, PGR, PPARA, PRKCD, PRKCG, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A |
2.37378 |
[BP] GO:0072488 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.35349 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.35349 |
[BP] GO:0090330 |
regulation of platelet aggregation
|
ALOX12, PRKCA, PRKCD |
2.35349 |
[BP] GO:0046626 |
regulation of insulin receptor signaling pathway
|
PRKCB, PRKCD, PTPN1, SRC |
2.34914 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, GRM5, IGF1R, MMP2, PRKCD, PTGS2, SRC, TRPV1 |
2.33784 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, PIK3CB, PTGS2, TNKS, TNKS2 |
2.33693 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA3, AKR1B1, APEX1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, HSD11B2, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SRC, TOP2A, TRPV1 |
2.33693 |
[BP] GO:0050878 |
regulation of body fluid levels
|
AKR1B1, ALOX12, F3, MET, PRKCA, PRKCD, PRKCE, SLC22A2, XDH |
2.30118 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTGS2, PTPN1, SRC |
2.2987 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.29422 |
[BP] GO:0050730 |
None
|
FLT3, GRM5, MIF, PRKCD, PRKCE, PTPN1, SRC |
2.28892 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, MIF, PRKCD, PTGS2 |
2.28892 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, GLO1, MIF, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.28297 |
[BP] GO:0010676 |
None
|
ESRRB, PPARA, PRKCE, SRC |
2.26473 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
2.24992 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.23459 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
ALOX12, BCL2, CYP1A1, CYP1A2, CYP1B1 |
2.22558 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX12, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, GLO1, MIF, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.20913 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PRKCE, PTGS2, SRC |
2.20913 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, KDR, PIK3CB, SRC |
2.20913 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX12, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, TYR |
2.20851 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
CDC25B, FLT3, GRM1, GRM5, MIF, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC |
2.2032 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AR, AXL, BCL2, CDC25B, CDK6, CYP1A1, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, KDR, MET, MIF, MMP2, MMP9, PGR, PRKCD, PTGS2, RORC, SRC, TOP2A |
2.19838 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.18142 |
[BP] GO:0015844 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.18142 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.18142 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, PRKCD, PTGS2, TRPV1, XDH |
2.16454 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, APEX1, AR, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP12, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PTGS2, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1 |
2.16386 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
MMP1, MMP12, MMP2, MMP9, TRPV1 |
2.16087 |
[BP] GO:0015874 |
None
|
SLC22A1, SLC22A2 |
2.15942 |
[BP] GO:1901374 |
None
|
SLC22A1, SLC22A2 |
2.15942 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.15942 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.15942 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.15942 |
[BP] GO:0050678 |
None
|
AR, CDK6, F3, KDR, MMP12, PGR, PRKCA, XDH |
2.15674 |
[BP] GO:1901342 |
regulation of vasculature development
|
ALOX12, CYP1B1, F3, KDR, PRKCA, PRKCB, PTGS2, XDH |
2.14884 |
[BP] GO:0019219 |
regulation of nucleobase-containing compound metabolic process
|
ADORA3, APEX1, AR, AURKB, CA9, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GRM3, GRM8, IGF1R, MET, MMP12, NR3C1, NR3C2, PGR, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCG, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TRPV1 |
2.1367 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.13661 |
[BP] GO:0050996 |
None
|
PPARA, PRKCD, PRKCE |
2.13661 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, GRM5, IGF1R, MMP2, PRKCD, PTGS2, SRC, TRPV1 |
2.12401 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, GRM5, IGF1R, KDR, MET, MIF, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC |
2.11423 |
[BP] GO:0002682 |
regulation of immune system process
|
AXL, BCL2, CA2, CDK6, CYP19A1, ESR1, ESRRA, MIF, MMP12, MMP2, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC |
2.11179 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, HSD11B2, PTGS2, SRC, TRPV1, TYR |
2.09817 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, ESR1, GRM1, GRM5, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.09165 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.0906 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.08747 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.08747 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
FLT3, GRM1, IGF1R, MIF, PIK3CB, PRKCD, PTPN1, SRC |
2.08355 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA3, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC22A1, SLC22A2, SRC, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
2.07275 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH |
2.07161 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.06989 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PRKCA, PTGS2 |
2.06516 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, MET, MMP9, PPARA, PRKCD, SRC, TNKS |
2.06516 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
APEX1, AR, ESR1, FLT3, NR3C1, PRKCD, PRKCE, SRC |
2.06516 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.04188 |
[BP] GO:0051338 |
regulation of transferase activity
|
AURKB, CDC25B, FABP4, FLT3, GRM1, GRM5, IGF1R, MIF, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC, TNKS |
2.02863 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
CDC25B, FLT3, GRM1, GRM5, MIF, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC |
2.0221 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9, RORC |
2.02021 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, AR, BCL2, ESR1, ESR2, IGF1R, MET, MIF, MMP12, MMP9, PRKCB, PRKCD, PTGS2, PTPN1, SRC, XDH |
2.01242 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
AURKB, BCL2, CDC25B, ESR1, F3, FLT3, GRM1, GRM5, MIF, PIK3CA, PIK3CB, PRKCD, PRKCE, PTPN1, SRC, TNKS, XDH |
2.01242 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA3, ALOX12, ALPL, AR, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, ESR1, F3, FLT3, GBA2, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TRPV1 |
5.81164 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA3, ALOX12, ALOX5, ALPL, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, F3, FLT3, FUT7, GBA2, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, MET, MMP2, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TNKS, TNKS2, TRPV1, TYR |
5.61517 |
[CC] GO:0098590 |
plasma membrane region
|
CA2, CA4, CA9, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, PRKCG, PTGS2, SLC1A1, SLC22A1, SRC, TRPV1 |
3.6915 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PRKCG, TRPV1 |
3.19104 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.06169 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CA1, CA2, CA4, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GRIA4, GRIK5, GRM1, GRM5, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, NQO2, NR3C1, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC22A2, SLC47A1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.72609 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX5, AOX1, APEX1, AR, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GRIA2, GRIA4, GRIK5, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MIF, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
2.58882 |
[CC] GO:0005829 |
cytosol
|
AKR1B1, AKR1B10, ALOX12, ALOX5, AOX1, AR, AURKB, BCL2, CA1, CA2, CA7, CDC25B, CDK6, CSNK2A1, FABP3, FABP4, FLT3, GLO1, HSD17B1, MIF, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
2.40193 |
[CC] GO:0044464 |
cell part
|
ACHE, ADORA3, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
2.37684 |
[CC] GO:0044456 |
None
|
ACHE, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PRKCG, SLC22A2, SRC, TRPV1 |
2.37119 |
[CC] GO:0005783 |
None
|
APEX1, BCL2, CA4, CYP19A1, FLT3, GBA2, GRIK5, KDR, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, XDH |
2.30591 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, AXL, CA4, F3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
2.29365 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA3, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, F3, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, MET, NR3C2, PIK3CA, PIK3CB, PRKCG, PTGS1, PTGS2, PTPN1, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TRPV1, TYR |
2.22827 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APEX1, CA4, PRKCA, PRKCD, PRKCE, PRKCG, SRC, TNKS2, TYR |
2.07372 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX5, AOX1, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC, TNKS, TYR, XDH |
18.8599 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC, TNKS |
12.2708 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
11.2999 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
9.48257 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, NR3C1, NR3C2, PGR, RORC |
9.38991 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.35438 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
9.05547 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX5, ALPL, AOX1, APEX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
8.87528 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
8.79126 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.70838 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA, RORC |
7.46441 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA, RORC |
7.46441 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX12, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TYR, XDH |
6.57608 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TRPV1 |
6.30645 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.14564 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, AR, AXL, CDK6, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TRPV1 |
5.74727 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.7331 |
[MF] GO:0004697 |
None
|
PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
5.63417 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, NR3C1, NR3C2, PGR, PPARA, RORC, TRPV1 |
5.61517 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TRPV1 |
5.4639 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, PRKCE, RORC, TRPV1 |
5.30811 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
5.24185 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
5.11304 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.8287 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB, PRKCD |
4.591 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
4.54584 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
4.46812 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.36321 |
[MF] GO:0004698 |
None
|
PRKCA, PRKCB, PRKCG |
4.21256 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
4.01141 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B2, HSD17B1, NQO2, PTGS1, PTGS2, SRC, XDH |
3.64387 |
[MF] GO:0005329 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.63436 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, SRC |
3.62653 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, NQO2, NR3C1 |
3.53219 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
3.53034 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, SRC |
3.44362 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.41434 |
[MF] GO:0015238 |
None
|
SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 |
3.31284 |
[MF] GO:0036094 |
small molecule binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, FABP3, FABP4, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SLC1A1, SRC, TOP2A, TRPV1, XDH |
3.23979 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.22165 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.17114 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, TYR |
3.16438 |
[MF] GO:0008504 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.12274 |
[MF] GO:0015651 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.12274 |
[MF] GO:0019899 |
enzyme binding
|
AR, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, ESR1, ESR2, ESRRB, F3, GRM5, MET, MIF, NR3C1, PGR, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS2, TOP2A |
3.10957 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, BCL2, CSNK2A1, ESR1, ESR2, FLT3, GRIK5, IGF1R, KDR, MET, MIF, MMP9, NQO2, PGR, PTGS2, SLC22A1, TOP2A, TRPV1, TYR, XDH |
3.07715 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.07398 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.06169 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
3.03648 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1, XDH |
2.92543 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1, XDH |
2.92384 |
[MF] GO:0009931 |
None
|
PRKCA, PRKCB, PRKCG |
2.87937 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.82745 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
2.79608 |
[MF] GO:0010857 |
None
|
PRKCA, PRKCB, PRKCG |
2.77579 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.76467 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.76467 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.76467 |
[MF] GO:0035403 |
None
|
PRKCA, PRKCB |
2.76467 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
2.68784 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.63674 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
2.57746 |
[MF] GO:0004674 |
protein serine/threonine kinase activity
|
AURKB, CDK6, CSNK2A1, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
2.55887 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TOP2A, TRPV1 |
2.54575 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.4805 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.4539 |
[MF] GO:0035173 |
histone kinase activity
|
AURKB, PRKCA, PRKCB |
2.40193 |
[MF] GO:0015307 |
None
|
SLC47A1, SLC47A2 |
2.39854 |
[MF] GO:1901375 |
None
|
SLC22A1, SLC22A2 |
2.39854 |
[MF] GO:0005333 |
None
|
SLC22A1, SLC22A2 |
2.39854 |
[MF] GO:0005277 |
None
|
SLC22A1, SLC22A2 |
2.39854 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.39854 |
[MF] GO:0008513 |
None
|
SLC22A1, SLC22A2 |
2.39854 |
[MF] GO:0004699 |
None
|
PRKCD, PRKCE |
2.39854 |
[MF] GO:0005231 |
None
|
GRIA2, GRIA4, GRIK5, TRPV1 |
2.37392 |
[MF] GO:0043168 |
anion binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SLC1A1, SRC, TOP2A, TRPV1, XDH |
2.35986 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.34914 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.29422 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.29422 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.15942 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.15942 |
[MF] GO:0030594 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.11987 |
[MF] GO:0015101 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.04188 |
[MF] GO:1901363 |
heterocyclic compound binding
|
AOX1, APEX1, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, MET, MMP12, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SRC, TOP2A, TRPV1, XDH |
2.0034 |